Miravo
Montreal-based specialty pharmaceutical company that in-licenses, acquires, and commercializes branded specialty pharmaceuticals and healthcare products. Operates a commercial platform for product launches, licensing and market access with a portfolio focused on women’s health, dermatology, allergy, neurology, pain management and hospital specialty markets.
Industries
Nr. of Employees
medium (51-250)
Miravo
Mississauga, Ontario, Canada, North America
Products
Commercial brand portfolio
A portfolio of over 65 marketed brands across women’s health, dermatology, allergy, neurology, pain management and hospital specialty markets in Canada.
Pipeline in‑licensed assets (selected)
In-licensed development and pre-registration stage products in dermatology and menopause therapeutic areas with planned Canadian regulatory filings.
Commercial brand portfolio
A portfolio of over 65 marketed brands across women’s health, dermatology, allergy, neurology, pain management and hospital specialty markets in Canada.
Pipeline in‑licensed assets (selected)
In-licensed development and pre-registration stage products in dermatology and menopause therapeutic areas with planned Canadian regulatory filings.
Services
End-to-end identification, negotiation and execution of licensing and supply agreements and management of partner relationships.
Commercial planning, sales and marketing execution, and distribution support for prescription, device and consumer health products.
Management of regulatory filings and approvals required to obtain market authorization and preparation of required product documentation.
Strategic development and in-market execution of reimbursement approaches to support patient access and commercial launches.
End-to-end identification, negotiation and execution of licensing and supply agreements and management of partner relationships.
Commercial planning, sales and marketing execution, and distribution support for prescription, device and consumer health products.
Management of regulatory filings and approvals required to obtain market authorization and preparation of required product documentation.
Strategic development and in-market execution of reimbursement approaches to support patient access and commercial launches.
Expertise Areas
- Commercialization of specialty pharmaceuticals
- Partnership, licensing and distribution management
- Regulatory submissions and product documentation (Health Canada, EU)
- Market access and reimbursement strategy
Key Technologies
- Health Canada and EU regulatory filing processes
- Licensing, contracting and commercial supply frameworks
- Product monograph and instructions-for-use development
- Commercial launch planning and sales channel execution
News & Updates
Completion of acquisition by Apotex Inc.
Announcement of agreement for acquisition by Apotex Inc.
License and supply agreement for Canadian rights to an investigational menopause treatment, including milestone and royalty terms; Searchlight to pursue Canadian regulatory submission.
Amendment to a licensing/supply agreement expanding territory and associated commercial terms with an international partner.
Video testimonial by a partner describing operational and in-house expertise in support of partnered commercialization.
Named in The Globe and Mail Top Growing Companies listings and Women Lead Here benchmarks across multiple years.
Completion of acquisition by Apotex Inc.
Announcement of agreement for acquisition by Apotex Inc.
License and supply agreement for Canadian rights to an investigational menopause treatment, including milestone and royalty terms; Searchlight to pursue Canadian regulatory submission.
Amendment to a licensing/supply agreement expanding territory and associated commercial terms with an international partner.
Video testimonial by a partner describing operational and in-house expertise in support of partnered commercialization.
Named in The Globe and Mail Top Growing Companies listings and Women Lead Here benchmarks across multiple years.